Your browser doesn't support javascript.
loading
Recipient hepatectomy technique may affect oncological outcomes of liver transplantation for hepatocellular carcinoma.
Pravisani, Riccardo; De Martino, Maria; Mocchegiani, Federico; Melandro, Fabio; Patrono, Damiano; Lauterio, Andrea; Di Francesco, Fabrizio; Ravaioli, Matteo; Zambelli, Marco Fabrizio; Bosio, Claudio; Dondossola, Daniele; Lai, Quirino; Zanchetta, Matteo; Dingfelder, Jule; Toti, Luca; Iacomino, Alessandro; Nicolae, Sermed; Ghinolfi, Davide; Romagnoli, Renato; De Carlis, Luciano; Gruttadauria, Salvatore; Cescon, Matteo; Colledan, Michele; Carraro, Amedeo; Caccamo, Lucio; Vivarelli, Marco; Rossi, Massimo; Nadalin, Silvio; Gyori, Georg; Tisone, Giuseppe; Vennarecci, Giovanni; Rostved, Andreas; De Simone, Paolo; Isola, Miriam; Baccarani, Umberto.
Affiliation
  • Pravisani R; Liver-Kidney Transplant Unit, Department of Medicine, University of Udine, Udine, Italy.
  • De Martino M; Division of Medical Statistic, Department of Medicine, University of Udine, Udine, Italy.
  • Mocchegiani F; HPB and Transplantation Unit, Department of Experimental and Clinical Medicine, United Hospital of Ancona, Polytechnic University of Marche, Ancona, Italy.
  • Melandro F; Division of Hepatic Surgery and Liver Transplantation, University Hospital of Pisa, Pisa, Italy.
  • Patrono D; General Surgery 2U, Liver Transplant Unit, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Turin, Torino, Italy.
  • Lauterio A; Department of Transplantation, Division of General Surgery and Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Di Francesco F; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
  • Ravaioli M; Department for the Treatment and Study of Abdominal Diseases and Abdominal Transplantation, IRCCS-ISMETT, UPMC (University of Pittsburgh Medical Center), Palermo, Italy.
  • Zambelli MF; General Surgery and Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Bosio C; Department of Organ Failure and Transplantation, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Dondossola D; USD Trapianti Epatici, AUOI Verona, Verona, Italy.
  • Lai Q; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Università degli Studi di Milano, Milano, Italy.
  • Zanchetta M; General Surgery and Organ Transplantation Unit, AOU Policlinico Umberto I, Sapienza University of Rome, Roma, Italy.
  • Dingfelder J; Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tubingen, Germany.
  • Toti L; Department of General Surgery, Division of Transplantation, Medical University of Vienna, Vienna, Austria.
  • Iacomino A; Transplant and HPB Unit, Department of Surgical Sciences, University of Rome Tor Vergata, Roma, Italy.
  • Nicolae S; UOC Hepato-biliary Surgery and Liver Transplant Centre, AORN Antonio Cardarelli, Napoli, Italy.
  • Ghinolfi D; Department of Surgery and Transplantation, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Romagnoli R; Division of Hepatic Surgery and Liver Transplantation, University Hospital of Pisa, Pisa, Italy.
  • De Carlis L; General Surgery 2U, Liver Transplant Unit, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Turin, Torino, Italy.
  • Gruttadauria S; Department of Transplantation, Division of General Surgery and Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Cescon M; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
  • Colledan M; Department for the Treatment and Study of Abdominal Diseases and Abdominal Transplantation, IRCCS-ISMETT, UPMC (University of Pittsburgh Medical Center), Palermo, Italy.
  • Carraro A; Department of Surgery, Medical and Surgical Specialties, University of Catania, Catania, Italy.
  • Caccamo L; General Surgery and Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Vivarelli M; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
  • Rossi M; Department of Organ Failure and Transplantation, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Nadalin S; USD Trapianti Epatici, AUOI Verona, Verona, Italy.
  • Gyori G; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy.
  • Tisone G; HPB and Transplantation Unit, Department of Experimental and Clinical Medicine, United Hospital of Ancona, Polytechnic University of Marche, Ancona, Italy.
  • Vennarecci G; General Surgery and Organ Transplantation Unit, AOU Policlinico Umberto I, Sapienza University of Rome, Roma, Italy.
  • Rostved A; Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tubingen, Germany.
  • De Simone P; Department of General Surgery, Division of Transplantation, Medical University of Vienna, Vienna, Austria.
  • Isola M; Transplant and HPB Unit, Department of Surgical Sciences, University of Rome Tor Vergata, Roma, Italy.
  • Baccarani U; UOC Hepato-biliary Surgery and Liver Transplant Centre, AORN Antonio Cardarelli, Napoli, Italy.
Liver Transpl ; 2024 Apr 01.
Article in En | MEDLINE | ID: mdl-38551397
ABSTRACT
To date, caval sparing (CS) and total caval replacement (TCR) for recipient hepatectomy in liver transplantation (LT) have been compared only in terms of surgical morbidity. Nonetheless, the CS technique is inherently associated with an increased manipulation of the native liver and later exclusion of the venous outflow, which may increase the risk of intraoperative shedding of tumor cells when LT is performed for HCC. A multicenter, retrospective study was performed to assess the impact of recipient hepatectomy (CS vs. TCR) on the risk of posttransplant HCC recurrence among 16 European transplant centers that used either TCR or CS recipient hepatectomy as an elective protocol technique. Exclusion criteria comprised cases of non-center-protocol recipient hepatectomy technique, living-donor LT, HCC diagnosis suspected on preoperative imaging but not confirmed at the pathological examination of the explanted liver, HCC in close contact with the IVC, and previous liver resection for HCC. In 2420 patients, CS and TCR approaches were used in 1452 (60%) and 968 (40%) cases, respectively. Group adjustment with inverse probability weighting was performed for high-volume center, recipient age, alcohol abuse, viral hepatitis, Child-Pugh class C, Model for End-Stage Liver Disease score, cold ischemia time, clinical HCC stage within Milan criteria, pre-LT downstaging/bridging therapies, pre-LT alphafetoprotein serum levels, number and size of tumor nodules, microvascular invasion, and complete necrosis of all tumor nodules (matched cohort, TCR, n = 938; CS, n = 935). In a multivariate cause-specific hazard model, CS was associated with a higher risk of HCC recurrence (HR 1.536, p = 0.007). In conclusion, TCR recipient hepatectomy, compared to the CS approach, may be associated with some protective effect against post-LT tumor recurrence.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Liver Transpl Journal subject: GASTROENTEROLOGIA / TRANSPLANTE Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Liver Transpl Journal subject: GASTROENTEROLOGIA / TRANSPLANTE Year: 2024 Document type: Article Affiliation country:
...